Risk of Venous Thromboembolism in Patients with Resectable Colorectal Cancer According to Stage

BACKGROUND: Venous thromboembolism (VTE) is a significant source of morbidity in patients undergoing colectomy and proctectomy for colorectal adenocarcinoma. However, the association between cancer stage and VTE risk is unclear. We aimed to describe the association between colorectal cancer stage and post-operative VTE among patients undergoing resection for colorectal cancer. METHODS: Utilizing the 2022-2023 American College of Surgeons National Surgical Quality Improvement Program database, a retrospective cohort study was conducted. A multivariable logistic regression analyzed the association between VTE and cancer stage with adjustments for covariates. RESULTS: Of 18,830 patients fitting inclusion criteria, 4,418 (23%) had stage I adenocarcinoma, 6,509 (35%) had stage II, 6,402 (34%) had stage III and 1,501 (8%) had stage IV; while 302 (2%) experienced postoperative VTE. On univariate analysis, patients with stage II, III and IV cancers had higher VTE rates than patients with stage I (stage I: 0.9%, stage II: 1.7%, stage III: 1.8%: stage IV 2.5%; p < 0.001). In the multivariable analysis of VTE risk, patients with stage II, III and IV cancer had higher odds of VTE relative to patients with stage I cancer (OR for stage II vs. I: 1.57; 95% confidence interval [CI]: 1.08, 2.27; p = 0.017; OR for stage III vs. I: 1.77; 95% CI: 1.22, 2.55; p = 0.002; OR for stage IV vs. I: 1.73, 95% CI:1.07, 2.79; p = 0.025). CONCLUSION: Resectable colorectal cancers at higher stages are associated with increased risk of VTE. Understanding the differences in risk can help clinicians make more informed and targeted treatment plans for patients undergoing colectomy or proctectomy for locoregional adenocarcinoma.

Authors

Institutions

Publication Details

Journal
Journal of Gastrointestinal Cancer
Published
2026-11-17
DOI
https://doi.org/10.1007/s12029-026-01628-2
Primary Topic
Venous Thromboembolism Diagnosis and Management
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Risk of Venous Thromboembolism in Patients with Resectable Colorectal Cancer According to Stage

Michael D. Honaker, C J Langfeldt, D Tumin, M A Holloway
2 links
Journal of Gastrointestinal Cancer
Venous Thromboembolism Diagnosis and Management
article

Risk of Venous Thromboembolism in Patients with Resectable Colorectal Cancer According to Stage

Michael D. Honaker, C J Langfeldt, D Tumin, M A Holloway
article en

Abstract

BACKGROUND: Venous thromboembolism (VTE) is a significant source of morbidity in patients undergoing colectomy and proctectomy for colorectal adenocarcinoma. However, the association between cancer stage and VTE risk is unclear. We aimed to describe the association between colorectal cancer stage and post-operative VTE among patients undergoing resection for colorectal cancer. METHODS: Utilizing the 2022-2023 American College of Surgeons National Surgical Quality Improvement Program database, a retrospective cohort study was conducted. A multivariable logistic regression analyzed the association between VTE and cancer stage with adjustments for covariates. RESULTS: Of 18,830 patients fitting inclusion criteria, 4,418 (23%) had stage I adenocarcinoma, 6,509 (35%) had stage II, 6,402 (34%) had stage III and 1,501 (8%) had stage IV; while 302 (2%) experienced postoperative VTE. On univariate analysis, patients with stage II, III and IV cancers had higher VTE rates than patients with stage I (stage I: 0.9%, stage II: 1.7%, stage III: 1.8%: stage IV 2.5%; p < 0.001). In the multivariable analysis of VTE risk, patients with stage II, III and IV cancer had higher odds of VTE relative to patients with stage I cancer (OR for stage II vs. I: 1.57; 95% confidence interval [CI]: 1.08, 2.27; p = 0.017; OR for stage III vs. I: 1.77; 95% CI: 1.22, 2.55; p = 0.002; OR for stage IV vs. I: 1.73, 95% CI:1.07, 2.79; p = 0.025). CONCLUSION: Resectable colorectal cancers at higher stages are associated with increased risk of VTE. Understanding the differences in risk can help clinicians make more informed and targeted treatment plans for patients undergoing colectomy or proctectomy for locoregional adenocarcinoma.

Journal of Gastrointestinal CancerVol. 57(1)
East Carolina University (US)
East Carolina University
Good health and well-being
Venous Thromboembolism Diagnosis and Management
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon